Register now and save 10% on Understanding Ketamine and Psychedelic Integration workshops this spring and fall! Use coupon code HEAL2021 at checkout.*
*Now through April 1 at midnight PST. Discount applies to workshops May-October 2021; does not apply to CE or CME.

Integrating Psychedelics with Evidence-Based Therapy | Online

This 12-week course will focus on the use of evidence-based therapies in psychedelic therapies.

RegisterCourse is FullCourse FullCourse Full

Event details

Integrating Psychedelics with Evidence-Based Therapy

Faculty

Alan K. Davis, PhD

Dates/Time

Thursdays, 5:30-7pm EDT (Eastern Time) from May 6th to July 22nd, 2021

5/6, 5/13, 5/20, 5/27, 6/3, 6/10, 6/17, 6/24, 7/1, 7/8, 7/15, 7/22

Location

Online

Cost

$1,200 for 12-sessions

Optional CE certificate for $65

To obtain your certificate, the CE form must be filled out within 14 days of class completion.

Certificate Program

This course can be taken in partial fulfillment of the requirements for the Fluence Postgraduate Certificate in Psychedelic Integration Therapy or Ketamine-assisted Psychotherapy.

Course Description

This reading and study group will maintain the same membership for the 12-week period. The group will have a syllabus with readings that participants will be expected to read prior to each discussion group meeting. The format for each session will include a short review of each paper by the group leader, followed by a discussion of the content and group members’ perspectives of the topic. This is an active group and weekly participation is required. The group is ideal for clinicians, graduate students, researchers, or the public, so long as they have training or interest in the scientific understanding of evidenced-based clinical interventions and their integration in psychedelic therapy. Readings will primarily include papers in the academic literature. Topics will include coverage of several different evidenced-based therapies (e.g., ACT, MI, CBT, PE, DBT), several types of psychedelics (e.g., psilocybin, ayahuasca, MDMA, ibogaine), and a variety of clinical populations (e.g., depression, social anxiety, addiction).

Weekly topics/readings:


Week 1: Review of Psychedelic Therapy
Week 2: Psilocybin for Depression
Week 3: Ibogaine Detoxification for Opioid Use Disorder
Week 4: Psilocybin for Long-term AIDS Survivors
Week 5: Therapeutic Mechanisms of Ayahuasca
Week 6: Psilocybin for Tobacco Addiction
Week 7: MDMA Therapy for PTSD with Couples
Week 8: Psilocybin for Alcohol Use Disorder
Week 9: Psychological Flexibility and Psychedelics
Week 10: MDMA for Autistic Adults
Week 11: Psychedelics and New Behaviorism
Week 12: Safety and Ethical Concerns of Psychedelic Therapy

Learning Objectives:  
At the end of the group, the participant will be able to:

1. Describe a variety of evidenced-based interventions that have been integrated into
psychedelic-assisted psychotherapy studies
2. Explain the role of psychotherapy in psychedelic treatment across a variety of clinical
populations
3. Critique the use of specific evidenced-based treatments as opposed to a supportive
psychotherapeutic approach.
4. Describe the ethical concerns related to the provision of evidenced-based interventions
within psychedelic therapy.
5. List the basic components of psychedelic therapy
6. Describe the ways in which the acute effects of psychedelics are related to
psychotherapeutic processes.
7. Explain the safety concerns related to psychedelic therapy.
8. Compare the different approaches to psychedelic therapy and evidenced-based
interventions
9. Explain the history of psychedelic therapy leading up to current trials.
10. Describe the basic pharmacology of psychedelic drugs.
11. List the features of the psychotherapeutic relationship that are critical to psychedelic
interventions.
12. Explain the role of psychological flexibility and how this may be a transdiagnostic feature of
evidenced-based interventions within the context of psychedelic therapy.


Accreditation

Information on Continuing Education Credit for Health Professionals (CE)

  • CE credits for psychologists are provided by the Spiritual Competency Academy (SCA) which is co-sponsoring this program. The Spiritual Competency Resource Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Spiritual Competency Resource Center maintains responsibility for this program and its content.
  • The California Board of Behavioral Sciences accepts CE credits for LCSW, LPCC, LEP, and LMFT license renewal for programs offered by approved sponsors of CE by the American Psychological Association.
  • LCSWs, MFTs, and other mental health professionals from states other than California need to check with their state licensing board as to whether or not they accept programs offered by approved sponsors of CE by the American Psychological Association.
  • SCA is approved by the California Board of Registered Nursing (BRN Provider CEP16887) for licensed nurses in California.
  • SCA is an approved CE provider for National Board Certified Health and Wellness Coaches (CEP Number 100196)
  • For questions about receiving your Certificate of Attendance, contact David Gumpel, David@fluence8.com. For questions about CE, visit www.spiritualcompetency.com or contact David Lukoff, PhD at CE@spiritualcompetency.com.